Generation Bio Co. (GBIO)
NASDAQ: GBIO · Real-Time Price · USD
5.42
-0.20 (-3.56%)
Nov 14, 2025, 4:00 PM EST - Market closed
Generation Bio Co. Market Cap
Generation Bio Co. has a market cap or net worth of $36.52 million as of November 14, 2025. Its market cap has decreased by -76.72% in one year.
Market Cap
36.52M
Enterprise Value
-27.01M
1-Year Change
-76.72%
Ranking
Category
Stock Price
$5.42
Market Cap Chart
Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.07B to $36.52M, a decrease of -96.59%. That is a compound annual growth rate of -46.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 14, 2025 | 36.52M | -48.42% |
| Dec 31, 2024 | 70.80M | -35.06% |
| Dec 29, 2023 | 109.03M | -53.31% |
| Dec 30, 2022 | 233.53M | -41.89% |
| Dec 31, 2021 | 401.89M | -68.88% |
| Dec 31, 2020 | 1.29B | 20.54% |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 915.86B |
| Johnson & Johnson | 470.41B |
| AbbVie | 410.55B |
| UnitedHealth Group | 301.21B |
| AstraZeneca | 276.17B |
| Novartis AG | 256.16B |
| Merck & Co. | 230.65B |
| Abbott Laboratories | 224.77B |